Latest filing published 01 Oct 2020 for MOMENTA PHARMACEUTICALS INC.
Filing timeline
BuySaleInsider track record
Agnieszka Cieplinska: trading record in brief
Agnieszka Cieplinska discloses dealings in Momenta Pharmaceuticals Inc to SEC (Form 4). The record holds 7 filings, for trades running from 12 April 2020 to 1 October 2020.
Sales make up the whole of the open-market record (3 sales, €79k). Besides market trades, the filings include 3 share grants.
On 1 October 2020 came the latest disclosure, a transaction in Momenta Pharmaceuticals Inc. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Agnieszka Cieplinska
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 8,136 sharesCommon StockSEC:0001179110-20-010054:0
- 947 shares@ US$35.1137.2% of flowCommon StockSEC:0001104659-20-080019:1
- 3,150 shares0Common StockSEC:0001104659-20-080019:0
- 940 shares@ US$30.1531.6% of flowCommon StockSEC:0001179110-20-007359:1
- 3,150 shares0Common StockSEC:0001179110-20-007359:0
- 921 shares@ US$29.5731.2% of flowCommon StockSEC:0001179110-20-004869:1
- 3,150 shares0Common StockSEC:0001179110-20-004869:0
7 of 7 declarations
